Clinical trial
A Real-world Study on Patients of Surgically Unsalvageable or Severe Post-surgery Morbidity Associated Giant Cell Tumor of Bone
NCT05402865 is registered in ClinicalTrials.gov with Shanghai JMT-Bio Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Real-world Study on Patients of Surgically Unsalvageable or Severe Post-surgery Morbidity Associated Giant Cell Tumor of Bone
- Lead sponsor
- Shanghai JMT-Bio Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 10, 2021
- Completion date
- February 18, 2022
- Enrollment
- 301 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.